Cargando…

Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction: A meta-analysis of randomized controlled trials

BACKGROUND: There is heated debate about the benefits of using mineralocorticoid receptor antagonists (MRAs) in addition to standard therapy in patients admitted for myocardial infarction (MI) with or without left ventricular dysfunction (LVD). METHODS: Randomized controlled trials (RCTs) were scann...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yan, Qiu, Zhiqiang, Yang, Renqiang, Wu, Yanqing, Cheng, Xiaoshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319977/ https://www.ncbi.nlm.nih.gov/pubmed/30572494 http://dx.doi.org/10.1097/MD.0000000000013690

Ejemplares similares

Recurrent Postmyocardial Infarction Ventricular Tachycardia: An Unusual Culprit
por: Sharma, Akhil Kumar, et al.
Publicado: (2015)

Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post‐ST‐Segment–Elevation Myocardial Infarction
por: Wong, Eric C., et al.
Publicado: (2021)

Postmyocardial Infarction Management and Rehabilitation
por: Wohlgelerntner, Daniel
Publicado: (1984)

Fatigue in Older Adults Postmyocardial Infarction
por: Crane, Patricia Barton, et al.
Publicado: (2016)

Abnormal Chest X-ray Postmyocardial Infarction
por: Abuosa, Ahmed M., et al.
Publicado: (2014)

Improvement of left ventricular ejection fraction in revascularized postmyocardial patients: indication for statistical fallacy
por: Reibis, Rona, et al.
Publicado: (2017)

Use of MitraClip for Postmyocardial Infarction Mitral Regurgitation Secondary to Papillary Muscle Dysfunction
por: Yasin, Muhammad, et al.
Publicado: (2018)

Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression
por: Hu, Yuan, et al.
Publicado: (2020)

Postmyocardial infarction education is effective but not enough on its own
por: Taylor, Rod
Publicado: (2021)

n-3 Fatty Acids, Ventricular Arrhythmia–Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients With Diabetes
por: Kromhout, Daan, et al.
Publicado: (2011)

Not all Postmyocardial Infarction Ventricular Septal Rupture Need Immediate Surgery: Role of Cardiogenic Shock Classification
por: Khandaker, Mohammed Azizul Hasan, et al.
Publicado: (2021)

Exercise training reduces insulin resistance in postmyocardial infarction rats
por: Wang, Youhua, et al.
Publicado: (2015)

Periodontitis is associated to increased systemic inflammation in postmyocardial infarction patients
por: Lira-Junior, Ronaldo, et al.
Publicado: (2021)

Site-specific prolongation of repolarization prevents postmyocardial infarction tachycardia
por: O’Hara, Ryan P., et al.
Publicado: (2023)

Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry
por: Borghi, Claudio, et al.
Publicado: (2015)

Use of Cyclic Backbone NGR-Based SPECT to Increase Efficacy of Postmyocardial Infarction Angiogenesis Imaging
por: Hendrikx, Geert, et al.
Publicado: (2017)

Commentary: “Belt and suspenders” or panacea: A hybrid approach to the complex problem of postmyocardial infarction ventricular septal defect
por: Bagameri, Gabor, et al.
Publicado: (2020)

Increased incidence of postmyocardial infarction ventricular septal defects during Covid‐19 pandemic: A case series
por: D' Abramo, M., et al.
Publicado: (2022)

The effect of self-management intervention program on the lifestyle of postmyocardial infarction patients
por: Amini, Roya, et al.
Publicado: (2021)

Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Optical projection tomography permits efficient assessment of infarct volume in the murine heart postmyocardial infarction
por: Zhao, X., et al.
Publicado: (2015)

Transcatheter Mitral Valve Repair to Treat Postmyocardial Infarction Papillary Muscle Rupture
por: Hayek, Ahmad, et al.
Publicado: (2021)

The safety and efficacy of low-dose mineralocorticoid receptor antagonists in dialysis patients: A meta-analysis
por: Zhu, Yifan, et al.
Publicado: (2021)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Postmyocardial Infarct Remodeling and Heart Failure: Potential Contributions from Pro- and Antiaging Factors
por: Idikio, Halliday A.
Publicado: (2011)

Effect of Acute Mental Stress on Heart Rate and QT Variability in Postmyocardial Infarction Patients
por: Magrì, Damiano, et al.
Publicado: (2012)

Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression
por: Liang, Jinjun, et al.
Publicado: (2015)

Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
por: Berbenetz, Nicolas M., et al.
Publicado: (2016)

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
por: Wu, Yichuan, et al.
Publicado: (2022)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

SAT-065 Adrenal Vein Sampling Without Discontinuation Of Mineralocorticoid-Receptor Antagonist Therapy
por: Ganesh, Malini, et al.
Publicado: (2019)

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic  Nephropathy
por: Goenka, Luxitaa, et al.
Publicado: (2019)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Vodošek Hojs, Nina, et al.
Publicado: (2021)

Mineralocorticoid receptor antagonists in cardiovascular translational biology
por: Chilton, Robert J., et al.
Publicado: (2023)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
por: Heinig, Roland, et al.
Publicado: (2023)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
por: Löfman, Ida, et al.
Publicado: (2018)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
Publicado: (2019)

Patient–provider communication, self-reported medication adherence, and race in a postmyocardial infarction population
por: Zullig, Leah L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nbdo0t13vn82h26vtofa4ecpo7